Gelonghui, January 8 | Huaxia Ophthalmology (301267.SZ) announced that the company plans to use its own funds to repurchase some of the company's shares through centralized bidding transactions to implement employee stock ownership plans or equity incentives. The total repurchase capital is not less than 150 million yuan and no more than 250 million yuan (all including capital). The repurchase price range does not exceed RMB 50.93 per share. Based on the maximum repurchase capital of 250 million yuan and the maximum repurchase price of 50.93 yuan/share, the estimated number of shares to be repurchased is about 49,086.98 million shares, accounting for 0.58% of the company's current total share capital; based on the total repurchase amount of 150 million yuan and the maximum repurchase price of 50.93 yuan/share, the estimated number of shares to be repurchased is approximately 2,9452.19 million shares, accounting for 0.35% of the company's current total share capital. The specific number of shares to be repurchased is based on the actual number of shares repurchased by the company at the end of the repurchase period or completion of the repurchase. The repurchase period begins when the board of directors of the company reviews and approves the repurchase of shares